SSY Group wins approval for hypertension drug tablets

SSY Group Limited obtained approval for drug production and registration of Benidipine Hydrochloride Tablets (8mg) from China's National Medical Products Administration. The product is classified as a type 4 chemical drug and has passed consistency evaluation.

The tablets treat primary hypertension and angina pectoris. The approval follows SSY Group's earlier registration of Benidipine Hydrochloride bulk drug in January 2025.